trending Market Intelligence /marketintelligence/en/news-insights/trending/Lm9zjmyVl6d3rp_CWGPTjw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

McKesson records 6% YOY rise in fiscal Q1 profit

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

McKesson records 6% YOY rise in fiscal Q1 profit

McKesson Corp.'s fiscal first-quarter adjusted earnings from continuing operations were $625 million, up 6% from $589 million in the prior-year period.

The San Francisco-based healthcare company's adjusted EPS from continuing operations for the first quarter of fiscal 2020 was $3.31, up year over year from $2.90.

The S&P Global Market Intelligence consensus normalized EPS estimate for the quarter ended June 30 was $3.01.

Revenue increased year over year to $55.73 billion from $52.61 billion.

On a GAAP basis, net loss from continuing operations attributable to the company was $429 million, or a loss of $2.27 per share, compared with a loss of $139 million, or a loss of 69 cents per share in the year-ago period.

For the first quarter, McKesson used cash from operations of $51 million and invested $111 million internally, resulting in negative free cash flow of $162 million. The company paid $46 million for acquisitions and returned $759 million of cash to shareholders via $684 million of common stock repurchases and $75 million of dividend payments.

The healthcare company said its board approved a 5% increase in the quarterly dividend to 41 cents per share.

McKesson raised fiscal 2020 adjusted EPS guidance to a range of $14 to $14.60 from a range of $13.85 to $14.45.

In addition, the company noted that after the completion of Change Healthcare Inc.'s IPO, McKesson owns about 58.5%, down from 70%. McKesson reaffirmed the guidance range for adjusted equity earnings from Change Healthcare of about $250 million to $270 million in fiscal 2020.